Trials / Completed
CompletedNCT05750056
Dose Systemic Lidocaine Improve the Quality of Recovery After Colorectal Endoscopic Submucosal Dissection
Effect of Intraoperative Intravenous Lidocaine on the Quality of Recovery Following Colorectal Endoscopic Submucosal Dissection
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 234 (actual)
- Sponsor
- Fujian Provincial Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Endoscopic submucosal dissection (ESD) is a common procedure that requires a long procedural time. Procedure Sedation is commonly provided to alleviate patients' discomfort and facilitate the implementation of procedures. We conducted a prospective study to determine the effect of intravenous infusion of lidocaine in the cognitive domain of the postoperative quality of recovery scale on day 3 after ESD.
Detailed description
Colorectal cancer occurred in more than 1.9 million new cases and 935,000 deaths in 2020 and ranked third in incidence and second in mortality globally. Endoscopic submucosal dissection (ESD) is the current standard for treating large colorectal polyps and has been shown to reduce colorectal cancer-related mortality. Sedation is commonly provided to alleviate patients' discomfort and facilitate the implementation of procedures. Lidocaine is an amide local anesthetic with analgesic, anti-hyperalgesic, and anti-inflammatory properties. Its safety in appropriate amounts has been established. The current evidence gap is whether the use of systematic lidocaine affects the quality of recovery after ESD. Thus, the aim of this study is to determine the effect of intravenous infusion of lidocaine in the cognitive domain of the postoperative quality of recovery scale on day 3 after ESD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lidocaine | Patients received an intravenous bolus injection of lidocaine 1.5 mg/kg over 10 min before induction of anesthesia, followed by a continuous infusion of 2 mg/kg/h until the end of the procedure. |
| DRUG | 0.9% saline | Patients received a perioperative saline infusion at the same rate and volume as the lidocaine infusion. |
| DRUG | Propofol | An i.v. bolus injection of propofol 1 mg/kg was given to all patients. Propofol was then titrated if necessary to produce unconsciousness during the introduction of the endoscope. Afterward, the anesthesiologist determined the dose of propofol and titrated to effect. |
| DRUG | Sufentanil | Sufentail 0.1 ug/kg was administered for sedation induction. |
Timeline
- Start date
- 2023-02-24
- Primary completion
- 2024-03-29
- Completion
- 2024-04-05
- First posted
- 2023-03-01
- Last updated
- 2024-05-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05750056. Inclusion in this directory is not an endorsement.